Bone Marrow Cells and Myocardial Regeneration

Overview

Journal Int J Hematol

Specialty Hematology

Date 2004 Jun 29

PMID 15218958

Citations 3

Authors

Fu-Sheng Wang

Cathy Trester

Affiliations

Soon will be listed here.

Abstract

Hematopoietic stem cell (HSC) plasticity and its clinical application have been studied profoundly in the past few years. Recent investigations indicate that HSC and other bone marrow stem cells can develop into other tissues. Because of the high morbidity and mortality of myocardial infarction and other heart disorders, myocardial regeneration is a good example of the clinical application of HSC plasticity in regenerative medicine. Preclinical studies in animals suggest that the use of this kind of treatment can reconstruct heart blood vessels, muscle, and function. Some clinical study results have been reported in the past 2 years. In 2003, reports of myocardial regeneration treatment increased significantly. Other studies include observations on the cell surface markers of transplanted cells and treatment efficacy. Some investigations, such as HSC testing, have focused on clinical applications using HSC plasticity and bone marrow transplantation to treat different types of disorders. In this review, we focus on the clinical application of bone marrow cells for myocardial regeneration.

Citing Articles

Calcium and cyclic nucleotides affect TNF-alpha-induced stem cell migration.

Kaplan E, Min J, Ke Q, Chen Y, Niethammer M, Rana J Biochem Biophys Res Commun. 2009; 382(2):241-6.

PMID: 19233128 PMC: 2941773. DOI: 10.1016/j.bbrc.2009.02.068.

Successful reduced-intensity hematopoietic stem cell transplantation in myelodysplastic syndrome with severe coronary artery disease.

Kosugi S, Hirokawa M, Kawabata Y, Hasegawa H, Yoshioka T, Miura I Int J Hematol. 2006; 83(2):156-8.

PMID: 16513535 DOI: 10.1532/IJH97.05057.

Issues in stem cell plasticity.

Filip S, English D, Mokry J J Cell Mol Med. 2004; 8(4):572-7.

PMID: 15601587 PMC: 6740252. DOI: 10.1111/j.1582-4934.2004.tb00483.x.

References

Pelled G, G T, Aslan H, Gazit Z, Gazit D . Mesenchymal stem cells for bone gene therapy and tissue engineering. Curr Pharm Des. 2002; 8(21):1917-28. DOI: 10.2174/1381612023393666. View

Penn M, Francis G, Ellis S, Young J, McCarthy P, Topol E . Autologous cell transplantation for the treatment of damaged myocardium. Prog Cardiovasc Dis. 2002; 45(1):21-32. DOI: 10.1053/pcad.2002.123466. View

Quaini F, Urbanek K, Beltrami A, Finato N, Beltrami C, Nadal-Ginard B . Chimerism of the transplanted heart. N Engl J Med. 2002; 346(1):5-15. DOI: 10.1056/NEJMoa012081. View

Dengler T, Katus H . Stem cell therapy for the infarcted heart ("cellular cardiomyoplasty"). Herz. 2002; 27(7):598-610. DOI: 10.1007/s00059-002-2412-5. View

Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F . Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A. 2001; 98(18):10344-9. PMC: 56963. DOI: 10.1073/pnas.181177898. View

Theise N . New principles of cell plasticity. C R Biol. 2002; 325(10):1039-43. DOI: 10.1016/s1631-0691(02)01525-1. View

Triffitt J . Stem cells and the philosopher's stone. J Cell Biochem Suppl. 2002; 38:13-9. DOI: 10.1002/jcb.10098. View

Menasche P . Cell transplantation for the treatment of heart failure. Semin Thorac Cardiovasc Surg. 2002; 14(2):157-66. DOI: 10.1053/stcs.2002.32319. View

Devine S, Peter S, Martin B, Barry F, McIntosh K . Mesenchymal stem cells: stealth and suppression. Cancer J. 2002; 7 Suppl 2:S76-82. View

10.

Kessler P, Byrne B . Myoblast cell grafting into heart muscle: cellular biology and potential applications. Annu Rev Physiol. 1999; 61:219-42. DOI: 10.1146/annurev.physiol.61.1.219. View

11.

Gojo S, Kyo S . [Regenerative potential of mesodermal stem cells for the heart]. Nihon Geka Gakkai Zasshi. 2002; 103(9):616-22. View

12.

Poulsom R, Alison M, Forbes S, Wright N . Adult stem cell plasticity. J Pathol. 2002; 197(4):441-56. DOI: 10.1002/path.1176. View

13.

Mertelsmann R . Plasticity of bone marrow-derived stem cells. J Hematother Stem Cell Res. 2001; 9(6):957-60. DOI: 10.1089/152581600750062417. View

14.

Tse H, Kwong Y, Chan J, Lo G, Ho C, Lau C . Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet. 2003; 361(9351):47-9. DOI: 10.1016/S0140-6736(03)12111-3. View

15.

Perry T, Kaushal S, Sutherland F, Guleserian K, Bischoff J, Sacks M . Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves. Ann Thorac Surg. 2003; 75(3):761-7; discussion 767. DOI: 10.1016/s0003-4975(02)03776-1. View

16.

Tisdale J, Dunbar C . Plasticity and hematopoiesis: Circe's transforming potion?. Curr Opin Hematol. 2002; 9(4):268-73. DOI: 10.1097/00062752-200207000-00002. View

17.

Orlic D . Stem cell repair in ischemic heart disease: an experimental model. Int J Hematol. 2002; 76 Suppl 1:144-5. DOI: 10.1007/BF03165227. View

18.

Keller R . Stem cells on the way to restorative medicine. Immunol Lett. 2002; 83(1):1-12. DOI: 10.1016/s0165-2478(02)00065-2. View

19.

Min J, Yang Y, Converso K, Liu L, Huang Q, Morgan J . Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol (1985). 2001; 92(1):288-96. DOI: 10.1152/jappl.2002.92.1.288. View

20.

Savitz S, Malhotra S, Gupta G, Rosenbaum D . Cell transplants offer promise for stroke recovery. J Cardiovasc Nurs. 2003; 18(1):57-61. DOI: 10.1097/00005082-200301000-00009. View